North American Neuromodulation Society


NANS strives to continually be engaged in advocacy activities that help promote the field of Neuromodulation. Through our Advocacy Committee and partner organizations, NANS reviews and works on programs and projects related to promoting the field of Neuromodulation. In addition, NANS collaborates with key stakeholders to ensure that patients have satisfactory access to Neuromodulation therapies as a treatment option and that the therapy is used effectively and appropriately. The group also maintains liaison with other key stakeholders, including: industry, government institutions and other interested/related parties to advocate for Neuromodulation as a treatment modality.

The NANS Advocacy and Policy Committee has worked tirelessly through various channels, including our association with the Multi-Society Pain Working Group, the AMA Specialty Section Council and our members’ own initiatives, to keep our members informed of activities and potential legislation that may impact the field of neuromodulation. One of the main benefits the Advocacy and Policy Committee has been providing is the drafting of a series of letters addressed to insurance carriers advocating for continued or improved coverage for neuromodulation treatments. Currently, we have submitted letters on NANS’ behalf regarding coverage for HF10 therapy, DRG and DBS. Samples of the letters are available in the resource center for members behind the member login page.  Members can feel free to use the letters as a guide in crafting your own letters as well, should you need to do so for any particular purpose.

Please look for regular updates from the Advocacy and Policy Committee in the NANS Newsletter as well as via e-mail.


NANS has also started a PR effort both independently and in collaboration with other specialty societies. Together, we are working on publicizing news articles and events that are taking place within the field of Neuromodulation. Currently, NANS is working on a PR pilot program in the state of California that consists of five test markets focusing on alternatives to opioids. 

PR plays a significant role in our advocacy efforts on behalf of patients and practitioners alike. NANS is developing an expanded page featuring news articles and other features where Neuromodulation is the primary focus. NANS encourages its members to submit articles of interest as well as any success stories from patients who have benefited from this therapy. Please submit all materials to NANS at

To learn more about how you can advocate for Neuromodulation as well as contribute to our PR efforts, please view the video posted here.

The video was produced in collaboration with the American Society of Interventional Pain Physicians (ASIPP).

To access members-only content from the NANS Advocacy page, you must be a member of NANS. Please log at the top of the page to access additional content. If you do not have membership and are interested, learn about our membership benefits.

Institute of Neuromodulation


Upcoming Events

  • April 22-28, 2017

    American Academy of Neurology
    Boston, Massachusetts

  • April 27-29, 2017

    The 2nd Annual Global Brain Health &
    Performance Summit
    Columbus, OH
    Visit website

  • April 27-30, 2017

    FSIPP Annual Conference & Trade Show
    Orlando, FL

  • May 15–19, 2017

    AAPA 2017
    American Academy of Physician Assistants
    Las Vegas, NV

  • May 27- June 1, 2017

    International Neuromodulation Society
    13th World Congress
    Edinburgh, Scotland

Contains 0 items
Subtotal: $0.00

Contains 0 items
Subtotal: $0.00